Compare · head to head
Champions Oncology vs Inotiv
Champions Oncology ranks higher overall — 360 rank 32 vs 16.
Champions Oncology leads on Value (59 vs 53), Quality (52 vs 47), Safety (34 vs 12) and Sentiment (54 vs 49).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | Small | Small |
| ISIN | US15870P3073 | US45783Q1004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 32 | 16 |
| Value | 59 | 53 |
| Quality | 52 | 47 |
| Growth | 31 | NR |
| Safety | 34 | 12 |
| Sentiment | 54 | 49 |
| Quality details | ||
| Profitability | 39 | 41 |
| Cash Truth | 65 | 53 |
Champions Oncology vs Tempus AIChampions Oncology vs Charles River LaboratoriesChampions Oncology vs PersonalisChampions Oncology vs Cytek BiosciencesAdd a third stock →
Full analyses: Champions Oncology · Inotiv
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100